Alpha Core Capital LLC Coh Bar, Inc. Transaction History

Alpha Core Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.17 - $0.34 $2,210 - $4,420	-13,000 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.09 - $1.49 $14,170 - $19,370	13,000 New	13,000 $18,000
Q1 2021 May 10, 2021	SELL	$1.26 - $2.02 $12,600 - $20,200	-10,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.9 - $1.54 $9,000 - $15,400	10,000 New	10,000 $13,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Core Capital LLC with notifications on news.